Passive immunization and its rebirth in the era of the COVID-19 pandemic-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Passive immunization and its rebirth in the era of the COVID-19 pandemic

Published:2021-03 Issue:3 Volume:57 Page:106275
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Pavia Charles S.,Wormser Gary P.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference28 articles.

1. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma;Shen;JAMA,2020

2. Effectiveness of convalescent plasma therapy in severe COVID-19 patients;Duan;Proc Natl Acad Sci U S A,2020

3. Landmarks and pioneers in the control of diphtheria;Dolman;Can J Public Health,1973

4. The College of Physicians of Philadelphia. Passive Immunization — History of Vaccines. www.historyofvaccines.org. Retrieved on 07-28-2020.

5. Report of the Lancet Special Commission on the relative strengths of diphtheria antitoxic serums;Lancet,1986

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune response against bacterial infection in organ transplant recipients;Transplant Immunology;2024-10

2. A comprehensive investigation of the anion inhibition profile of a β-carbonic anhydrase from Acinetobacter baumannii for crafting innovative antimicrobial treatments;Journal of Enzyme Inhibition and Medicinal Chemistry;2024-07-16

3. Dual neutralization of influenza virus hemagglutinin and neuraminidase by a bispecific antibody leads to improved antiviral activity;Molecular Therapy;2024-07

4. SIR+ models: accounting for interaction-dependent disease susceptibility in the planning of public health interventions;Scientific Reports;2024-06-05

5. The major epidemiologic, microbiologic, immunologic, and clinical aspects of Lyme disease that form the basis for a newly developed vaccine that may become available soon for human use;Frontiers in Immunology;2024-02-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3